The Latest News for the PF Community

Want to learn about the latest advances in PF research, clinical trials, health care, and more? Explore press releases and articles of interest to PF patients, caregivers and medical professionals.

Featured News

  • Virtual Broadway Belts for PFF! Raises Over $346,000 for the Pulmonary Fibrosis Foundation

    The 11th annual Broadway Belts for PFF! hosted by Broadway actress and comedienne Julie Halston (Broadway’s Tootsie, Gypsy, You Can’t Take It With You, TV’s Sex and the City), showcased 35 Broadway stars in a virtual benefit for the Pulmonary Fibrosis Foundation (PFF). The event, which broadcasted live on March 12, raised over $346,000 to fight pulmonary fibrosis (PF), a life-threatening disease that causes progressive scarring in the lungs. More than 200,000 Americans are living with PF.

  • Pulmonary Fibrosis Foundation Announces Sponsorship by United Therapeutics

    The PFF has announced United Therapeutics’ sponsorship of the PFF Registry, a research resource that tracks clinical data, blood samples and patient-reported outcomes from individuals living with PF nationwide.

  • First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis

    The Pulmonary Fibrosis Foundation announced enrollment of the first patient in PRECISIONS ​(Prospective tReatment EffiCacy in IPF uSIng genOtype for Nac Selection) clinical trial. This is the first clinical trial to apply the principles of precision medicine to the treatment of patients with idiopathic pulmonary fibrosis (IPF).

  • The Importance of SARS-CO-V-2 Vaccination to Prevent COVID-19 and its Impact in the Pulmonary Fibrosis Community

    In accordance with Recommendations issued by the Centers for Disease Control and Prevention, the Pulmonary Fibrosis Foundation strongly encourages vaccination for COVID-19, as the benefits far outweigh the risks. The two authorized vaccines have been demonstrated to be safe and extremely effective in preventing COVID-19 and/or limiting the development of severe COVID-19.

  • Pulmonary Fibrosis Foundation Chief Medical Officer To Depart For Industry Role

    The Pulmonary Fibrosis Foundation (PFF), the nation’s leading pulmonary fibrosis (PF) education and advocacy organization, announces the departure of Chief Medical Officer (CMO) Gregory P. Cosgrove, MD who will join Pliant Therapeutics, a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related disease, as Vice President, Clinical Development (IPF), effective December 31, 2020.

  • Pulmonary Fibrosis Foundation Launches Campaign ​To Raise PF Awareness And Early Diagnosis

    The Pulmonary Fibrosis Foundation today announced the “Pinpoint PF” education and awareness campaign aimed at individuals with symptoms and at a higher risk for pulmonary fibrosis (PF).


    The Pulmonary Fibrosis Foundation (PFF) has developed a new logo, which features powerful lettering with an abstract pair of lungs in the organization’s signature teal and green colors.

  • Julie Halston Joins Pulmonary Fibrosis Foundation Board of Directors

    The Pulmonary Fibrosis Foundation (PFF), the nation’s leading pulmonary fibrosis (PF) patient education and advocacy organization, has appointed actress and comedienne, Julie Halston, to its Board of Directors.

  • Pulmonary Fibrosis Awareness Month Set to Celebrate Pulmonary Fibrosis Heroes

    September marks Pulmonary Fibrosis Awareness Month, presented by the Pulmonary Fibrosis Foundation (PFF) to spread the word about pulmonary fibrosis (PF), a progressive, incurable lung disease with different causes affecting more than 200,000 people in the U.S. While more than 50,000 new cases are diagnosed annually, awareness of PF symptoms, which include shortness of breath, fatigue and a dry, hacking cough, remains very low for a vast majority (86%) of Americans, according to the PFF.

  • The Pulmonary Fibrosis Foundation’s Commitment to Equality

    The Pulmonary Fibrosis Foundation is committed to its mission to drive research and act as the trusted resource for individuals afflicted with pulmonary fibrosis. We exist to serve people of every race and background, and we know that the suffering resulting from PF is often accompanied by other painful hardships borne by patients and their loved ones.

  • Pulmonary Fibrosis Foundation Expands Medical Team

    The Pulmonary Fibrosis Foundation (PFF) announced the appointment of three highly respected pulmonologists as senior members of its medical team. The new team members are: Dr. Amy Hajari Case of Piedmont Healthcare (Atlanta); Dr. Sonye Danoff of the Johns Hopkins University School of Medicine (Baltimore); and Dr. Joyce Lee of the University of Colorado Anschutz Medical Campus (Aurora). They will bring a combined 40-plus years of expertise in treating individuals with interstitial lung disease (ILD).

  • 86% of Americans Do Not Know Symptoms of Pulmonary Fibrosis

    Pulmonary Fibrosis Foundation National Awareness Survey reveals little understanding of disease in advance of Rare Disease Week.


footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >